Skip to the page

Data / Form D filings / Fidelis Animal Health Inc.

Fidelis Animal Health Inc.: Form D filings

Fidelis Animal Health Inc., a pharmaceuticals company in North Brunswick, NJ, filed 2 Form D notices with the SEC between 2021 and 2024. The latest, on February 28, 2024, reports $1 million sold of a $2 million offering to 10 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
685 US HIGHWAY ONE, SUITE 265, North Brunswick, NJ, 08902
Phone
(215) 262-2078
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1869472

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 28, 2024New notice$2,000,001$1,000,017$999,98410Feb 16, 2024sec.gov
Jul 21, 2021New notice$5,129,692$5,129,6928Apr 26, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Andrew MidlerDirector
Michael WellsExecutive Officer, Director, Promoter
Susan WithamExecutive Officer
Dennis SteadmanDirector
Steven LearyExecutive Officer
Barry LevinsonExecutive Officer, Director, Promoter
Cynthia DavisExecutive Officer

Other pharmaceuticals companies in New Jersey that filed recently

Every Form D from the week of Feb 26, 2024 · All recent filings in New Jersey · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Fidelis Animal Health Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.